Gerard Jaouen Selected Research

ferrociphenol

1/2018	Aryl Butenes Active against K562 Cells and Lacking Tyrosinase Inhibitory Activity as New Leads in the Treatment of Leukemia.
12/2011	Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerard Jaouen Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2008
2	Glioma (Gliomas) 11/2014 - 12/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018
1	Leukemia 01/2018
1	Neoplasms (Cancer) 11/2014
1	Brain Neoplasms (Brain Tumor) 11/2014
1	Gliosarcoma 12/2011

Drug/Important Bio-Agent (IBA)

2	ferrociphenolIBA 01/2018 - 12/2011
2	Hormones (Hormone)IBA 01/2018 - 01/2008
2	NanocapsulesIBA 11/2014 - 12/2011
2	Pharmaceutical PreparationsIBA 11/2014 - 01/2008
2	LipidsIBA 11/2014 - 12/2011
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2018
1	butyleneIBA 01/2018
1	monophenolaseIBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	afimoxifene (hydroxytamoxifen)IBA 01/2018
1	Melanins (Melanin)IBA 01/2018
1	CyclodextrinsIBA 01/2008
1	ferrocifenIBA 01/2008
1	Tamoxifen FDA LinkGeneric 01/2008

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 11/2014 - 12/2011
2	Intravenous Injections 11/2014 - 12/2011
1	Therapeutics 11/2014